Han-Oh Park
Vorstandsvorsitzender bei BIONEER CORPORATION
Vermögen: 87 Mio $ am 30.04.2024
Profil
Han-Oh Park currently works at BIONEER Corp., as Chief Executive Officer & Director from 2011, Korea Biotechnology Industry Organization, as Vice Chairman from 2002, Bioneer, Inc., as Director, Resource Ventures, Ltd.
(KR), as Director, AceBiomed, Inc., as Director, and Sirnagen Therapetics Co. Ltd., as Director.
Dr. Park received his undergraduate degree from Seoul National University and graduate degree and doctorate degree from Korea Advanced Institute of Science & Technology.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
BIONEER CORPORATION
15,25% | 28.03.2024 | 3 936 997 ( 15,25% ) | 87 Mio $ | 30.04.2024 |
Aktive Positionen von Han-Oh Park
Unternehmen | Position | Beginn |
---|---|---|
BIONEER CORPORATION | Vorstandsvorsitzender | 01.08.1992 |
Bioneer, Inc.
Bioneer, Inc. Miscellaneous Commercial ServicesCommercial Services Bioneer, Inc. engages in the provision of solutions to the community of life science researchers in academia, biotech, and pharmaceutical companies. It offers protein expression and purification, gene synthesis service, ladders and markers, and drug target and toxicity identification services. The company is headquartered in Alameda, CA. | Direktor/Vorstandsmitglied | - |
Resource Ventures, Ltd. (KR)
Resource Ventures, Ltd. (KR) BiotechnologyHealth Technology Resource Ventures, Ltd. (KR) is a South Korean biotechnology company. | Direktor/Vorstandsmitglied | - |
Korea Biotechnology Industry Organization | Direktor/Vorstandsmitglied | 01.01.2002 |
AceBiomed, Inc.
AceBiomed, Inc. Medical SpecialtiesHealth Technology AceBiomed, Inc. is engaged in the manufacturing of medical equipment. The company was founded on April 3, 2001 and is headquartered in Jinju-si, South Korea. | Direktor/Vorstandsmitglied | - |
Sirnagen Therapetics Co. Ltd.
Sirnagen Therapetics Co. Ltd. Information Technology ServicesTechnology Services Sirnagen Therapeutics Co. Ltd. is a South Korean company that operates as a seed stage RNAi platform technology company. | Direktor/Vorstandsmitglied | - |
Ausbildung von Han-Oh Park
Seoul National University | Undergraduate Degree |
Korea Advanced Institute of Science & Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIONEER CORPORATION | Health Technology |
Private Unternehmen | 5 |
---|---|
Bioneer, Inc.
Bioneer, Inc. Miscellaneous Commercial ServicesCommercial Services Bioneer, Inc. engages in the provision of solutions to the community of life science researchers in academia, biotech, and pharmaceutical companies. It offers protein expression and purification, gene synthesis service, ladders and markers, and drug target and toxicity identification services. The company is headquartered in Alameda, CA. | Commercial Services |
Resource Ventures, Ltd. (KR)
Resource Ventures, Ltd. (KR) BiotechnologyHealth Technology Resource Ventures, Ltd. (KR) is a South Korean biotechnology company. | Health Technology |
Korea Biotechnology Industry Organization | |
AceBiomed, Inc.
AceBiomed, Inc. Medical SpecialtiesHealth Technology AceBiomed, Inc. is engaged in the manufacturing of medical equipment. The company was founded on April 3, 2001 and is headquartered in Jinju-si, South Korea. | Health Technology |
Sirnagen Therapetics Co. Ltd.
Sirnagen Therapetics Co. Ltd. Information Technology ServicesTechnology Services Sirnagen Therapeutics Co. Ltd. is a South Korean company that operates as a seed stage RNAi platform technology company. | Technology Services |